Evidence map›Paper›PMID 41465504›Full record

ArticleInternational journal of molecular sciences2025

Synthesis and Evaluation of Novel 2-((1

Athul S, Bhuvaneshwari S V, Avani Anu G, Parvathi Mohanan P C, Anu R Melge, Aravind Madhavan, Bipin G Nair, Geetha Kumar, Vipin A Nair, Pradeesh Babu

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Athul SAmrita School of Biotechnology, Amrita Vishwa Vidyapeetham, Kollam 690525, Kerala, India.
Bhuvaneshwari S VRukmini Educational Trust, REVA University, Bengaluru 560064, Karnataka, India.
Avani Anu GAmrita School of Biotechnology, Amrita Vishwa Vidyapeetham, Kollam 690525, Kerala, India.
Parvathi Mohanan P CAmrita School of Biotechnology, Amrita Vishwa Vidyapeetham, Kollam 690525, Kerala, India.
Anu R MelgeAmrita School of Biotechnology, Amrita Vishwa Vidyapeetham, Kollam 690525, Kerala, India.ORCID 0000-0002-9593-5006
Aravind MadhavanAmrita School of Biotechnology, Amrita Vishwa Vidyapeetham, Kollam 690525, Kerala, India.
Bipin G NairAmrita School of Biotechnology, Amrita Vishwa Vidyapeetham, Kollam 690525, Kerala, India.
Geetha KumarAmrita School of Biotechnology, Amrita Vishwa Vidyapeetham, Kollam 690525, Kerala, India.ORCID 0000-0002-4584-6929
Vipin A NairAmrita School of Biotechnology, Amrita Vishwa Vidyapeetham, Kollam 690525, Kerala, India.
Pradeesh BabuAmrita School of Biotechnology, Amrita Vishwa Vidyapeetham, Kollam 690525, Kerala, India.ORCID 0000-0003-0569-6628

Funding

DST- Government of India DST/TTI/TC/AMR/CoE/2023/53)
6 · The paper itself

Abstract

This study details the design, synthesis, and evaluation of a novel series of fourteen 2-((1

Indexed as

Anti-Bacterial AgentsAnti-Infective AgentsHydrazinesTriazolesGram-Negative BacteriaGram-Positive BacteriaHEK293 CellsHumansMicrobial Sensitivity TestsStructure-Activity RelationshipAnti-Bacterial AgentsAnti-Infective AgentsHydrazinesTriazoles2-((1H-1,2,4-triazol-5-yl)thio)-N-benzylidene-N-arylacetohydrazide hybridantibacterial agentsantimicrobial resistanceSwissADME

Identifiers

PMID41465504
PMCPMC12732608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.